Results 1 to 10 of about 1,935,200 (187)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform

Clinical Medicine Insights: Cardiology, 2013
Everolimus-eluting stents (EES) represent the next generation of drug-eluting stents (DES). Important design modifications include thin strut stent backbones, less inflammatory and more biocompatible polymers, and lower drug dosing.
Matthew G. Whitbeck, Robert J. Applegate
doaj   +2 more sources

Advances in Drug Delivery via Biodegradable Ureteral Stent for the Treatment of Upper Tract Urothelial Carcinoma

Frontiers in Pharmacology, 2020
Drug eluting ureteral stent is an effective means for local drug delivery to the urinary tract. It can potentially solve a variety of upper urinary tract problems, such as stent-related urinary tract infections and discomfort, ureteral stricture, and ...
Hongli Shan, Zhongshuai Cao, Changliang Chi, Jixue Wang, Xiaoqing Wang, Jingyan Tian, Bing Yu   +6 more
doaj   +1 more source

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost

SAGE Open Medical Case Reports, 2016
Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies.
Alev Arat Ozkan, Umit Yasar Sinan, Aziz T Gurmen   +2 more
doaj   +1 more source

Long-term effectiveness and safety of sirolimus drug-eluting stents

Medical Devices: Evidence and Research, 2011
Mahesh Bikkina, Jayanth KoneruSt Joseph Regional Medical Center, Paterson, Seton Hall University, NJ, USAAbstract: The root cause of coronary artery disease is atherosclerosis, ie, intraluminal narrowing (stenosis) of the arteries that supply blood to ...
Bikkina M, Koneru J
doaj  

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)

Revista Colombiana de Cardiología, 2012
Introducción y objetivos: los stents convencionales presentan tasas de restenosis intrastent entre 10% y 60%, mientras los stents liberadores de fármacos alcanzan el 10%. Para Latinoamérica, no hay reportes de restenosis intrastent en comparación con los
Jorge A Arroyave C, Magda C Cepeda G
doaj  

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents

BMC Cardiovascular Disorders, 2022
Background Coronary artery aneurysms after drug eluting stents are rare. We present a case series of type II coronary aneurysms after implantation of Everolimus eluting stents including patients developing giant aneurysms with a toxic course.
Raghav Sharma, Aditya Vikram Ruia, Tek Singh Mahant   +2 more
doaj   +1 more source

Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach

Journal of Cardiothoracic Surgery, 2022
Background Introduction of Bare Metal Stents (BMS) was itself a revolutionary step in the history of the medical industry; however, Drug Eluting Stents (DES) maintained its superiority over BMS in every aspect from restenosis rate to late lumen loss. The
Sadia Hassan, Murtaza Najabat Ali, Bakhtawar Ghafoor   +2 more
doaj   +1 more source

Immediate Small Side Branch Occlusion after Percutaneous Coronary Intervention [PDF]

Journal of Tehran University Heart Center, 2007
Background: Small side branches, albeit less important than their larger counterparts, have not yet received due attention in the literature. Nor has there ever been a comparison between drug-eluting stents and bare metal stents apropos side branch ...
Mohammad Ali Ostovan, Reza Mollazadeh
doaj   +1 more source

Interfacing exogenous stents with human coronary artery by self-assembled coating: designs, functionalities and applications

NPG Asia Materials
Drug-eluting stents are a commonly used treatment for coronary artery disease. However, the coatings used in drug-eluting stents have some limitations such as poor biocompatibility and drug loading capacity.
Feng Zhao, Feng Liu, Chenglong Gao, Guoqing Wang, Yinfeng Zhang, Fei Yu, Jiawei Tian, Kai Tan, Runhao Zhang, Kang Liang, Zhexun Lian, Junjie Guo, Biao Kong, Junbo Ge, Hui Xin   +14 more
doaj   +1 more source

Advances in stent technologies and their effect on clinical efficacy and safety

Medical Devices: Evidence and Research, 2014
Navin Nikam, Toby B Steinberg, Daniel H SteinbergDivision of Cardiology, Medical University of South Carolina, Charleston, SC, USAAbstract: The introduction of intracoronary stents represented a major advance in interventional cardiology.
Nikam N, Steinberg TB, Steinberg DH
doaj